Over-65s rebate cut: 44,000 may drop cover, AMA warns of hospital strain

For clinicians and health-system planners, the over-65s rebate change is not a fiscal abstraction — it is a clinical risk. Older Australians told a Senate inquiry they would cut spending on GPs and specialists before surrendering private cover they feel duty-bound to hold, a trade-off that delays diagnosis and shifts treatment into the acute, high-cost public system. With public hospitals already under considerable strain, the AMA warns the $3 billion in budget savings could be clawed back through emergency and public-sector admissions.

The Australian government is pressing ahead with a budget measure to end the age-based loading on private health insurance rebates for people over 65, a change projected to save $3 billion over four years and now the subject of contested evidence at a Senate inquiry. Announced ahead of the May 2026 federal budget, the measure removes a differential worth up to eight percentage points: some older Australians currently receive roughly eight per cent more in rebate than younger citizens on identical incomes. Supporters frame it as a simplification that ends special treatment; critics, led by the Australian Medical Association, argue the headline saving is a mirage that will simply shift costs from the federal ledger onto public hospitals and older patients.

“

University of Melbourne researchers put the figure as low as 12,000 — a nearly fourfold gap that determines whether the projected $3 billion saving survives contact with reality.

Australia's private health insurance rebate is a long-standing, means-tested subsidy designed to keep people in private cover and relieve pressure on the public Medicare system. The age-based loading has functioned as a retention incentive for a cohort that is more expensive to insure and more likely to need hospital care. Removing it reverses a deliberate policy lever at a moment when, as the AMA notes, the private health sector faces significant pressures and public hospitals are under considerable strain. That timing is central to the AMA's objection: the measure targets a vulnerable demographic precisely when the safety net they would fall back onto is already stretched.

The empirical heart of the debate is how many people will actually drop out. Government modelling estimates about 44,000 policyholders would cancel their insurance under the changes. University of Melbourne researchers put the figure as low as 12,000 — a nearly fourfold gap that determines whether the projected $3 billion saving survives contact with reality. If cancellations cluster at the upper bound, the public system absorbs thousands of additional patients for elective and semi-elective procedures, eroding waiting-list gains and converting a budget saving into hospital expenditure. If the lower bound holds, the saving is more durable but still falls unevenly on fixed-income retirees.

AMA president Danielle McMullen told the inquiry she was unconvinced the bill would save any money, warning that it removes a long-standing incentive for older Australians to maintain private cover. Her concern reflects a classic cost-shifting dynamic: every policyholder who exits private insurance moves their care into the public queue, where access is rationed by waiting time rather than price. The quote captures the tension between fiscal accounting and system-wide cost — a saving booked in one portfolio can reappear as demand in another.

A more insidious risk emerged in the testimony of older Australians themselves. McMullen warned that those who feel duty-bound to maintain insurance may not cancel at all, but instead absorb higher premiums by forgoing GP visits, specialist consultations and other care. Mary, an 83-year-old retired nurse, personified that trade-off: she and her husband cut their costs to keep private insurance so they could free up a public hospital bed, describing a life with no luxuries but simple pleasures, such as reading. This substitution — skimping on primary and preventive care to preserve hospital cover — is clinically counterproductive. It delays diagnosis, converts manageable chronic conditions into acute, high-cost presentations, and ultimately raises long-term system costs while worsening outcomes for the very cohort the rebate was meant to protect.